For the year ending 2025-12-31, JSPR has $35,779K in assets. $31,628K in debts. $28,692K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 28,692 | |||
| Prepaid expenses and other current assets | 5,953 | |||
| Total current assets | 34,645 | |||
| Property and equipment, gross | 4,916 | |||
| Less accumulated depreciation and amortization | 4,814 | |||
| Property and equipment, net | 102 | |||
| Operating lease right-of-use assets | 502 | |||
| Restricted cash | 417 | |||
| Other non-current assets | 113 | |||
| Total assets | 35,779 | |||
| Accounts payable | 6,220 | |||
| Current portion of operating lease liabilities | 1,235 | |||
| Accrued expenses and other current liabilities | 5,745 | |||
| Total current liabilities | 13,200 | |||
| Warrant liability | 16,164 | |||
| Other non-current liabilities | 2,264 | |||
| Total liabilities | 31,628 | |||
| Common stock 0.0001 par value 492,000,000 shares authorized at december 31, 2025 and 2024 27,996,819 and 15,022,122 shares issued and outstanding at december 31, 2025 and 2024, respectively | 3 | |||
| Additional paid-in capital | 320,818 | |||
| Accumulated deficit | -316,670 | |||
| Total stockholders equity | 4,151 | |||
| Total liabilities and stockholders equity | 35,779 | |||
Jasper Therapeutics, Inc. (JSPR)
Jasper Therapeutics, Inc. (JSPR)